Abstract:Aerobic exercise is increasingly examined for its efficacy on preventing and treating Alzheimer's disease (AD) because it could potentially improve brain structure and function. However, its reported effects in AD have been controversial with limited studies, which are largely attributable to: wide variations and insufficient doses of prescribed aerobic exercise. The standard measures in drug trials, e.g., the AD Assessment Scale - cognition (ADAS-cog), have not been used in exercise studies. This study pilot tested how 6-month cycling affects ADAS-cog and other symptoms using a single-blinded, single-group, repeated-measures design in older adults with mild to moderate AD. The ADAS-cog, Disability in AD (DAD), and Neuropsychiatric Inventory (NPI-Q) were administered at baseline, 3 and 6 months. Of the 28 enrolled subjects (Table 1), 26 completed 3-month data collection and 22 completed 6-month data collection. Missing 6-month data were imputed for four participants as follows to prevent artificially improve the a) If the 3-month values were higher than baseline values (indicating outcome worsening), this increase was added to the 3-month values to estimate the missing 6-month values; and b) If the 3-month values were lower than baseline values (indicating outcome improvement), then the 3-month values were imputed as the 6-month values. Analyses were performed using mixed linear model in SAS and graphs were drawn using R project. Participants > age 65 years did not increase their ADAS-cog scores from baseline while those ≤ age 65 did (Table 2). This difference between age groups was highly significant (p = .004 for age-study-month interaction). Participants > age 65 maintained their baseline ADAS-cog score on average, with 95% confidence interval (-2.4 to 2.9) for the change (Table 2 and Figure 1). In addition, participants maintained DAD and NPI-Q severity scores over time (Table 2) with no age differences in changes. Caregiver distress significantly decreased almost 40% from baseline (p < .05). The stability of ADAS-cog is highly significant because older adults with mild to moderate AD receiving placebo in AD drug trials increased 2.4 - 3.9 points. Aerobic exercise maintained function and neuropsychiatric symptoms, while substantially reduced caregiver distress. 6-month change in ADAS-cog by participant's baseline age. Observed changes are shown by black filled circles; imputed changes are shown by gray filled circles. Correlation between age and 6m change in ADAS-cog was r = –.38 (p = .054).

Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial

High intensity aerobic exercise improves information processing and motor performance in individuals with Parkinson’s disease

Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease

Aerobic Exercise Training Improves Cerebral Blood Flow and Executive Function: A Randomized, Controlled Cross-Over Trial in Sedentary Older Men

Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial

Influence of Aerobic Exercise on Functional Capacity and Maximal Oxygen Uptake in Patients With Parkinson Disease: A Systematic Review and Meta-analysis

Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial

Mechanistic Effects of Aerobic Exercise in Alzheimer's Disease: Imaging Findings from the Pilot FIT-AD Trial

Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.

Current Perspectives on Aerobic Exercise in People with Parkinson’s Disease

Aerobic Exercise Improves Cortical Inhibitory Function After Stroke: A Preliminary Investigation

Aerobic exercise improves motor dysfunction in Parkinson's model mice via differential regulation of striatal medium spiny neuron

P4-171: aerobic exercise in alzheimer's disease: the fit-ad trial

P2–329: How Aerobic Exercise Affects Cognition: A Pilot Study

Aerobic Exercise in People with Schizophrenia: Neural and Neurocognitive Benefits

Effects and Mechanisms of Exercise on Brain-Derived Neurotrophic Factor (BDNF) Levels and Clinical Outcomes in People with Parkinson's Disease: A Systematic Review and Meta-Analysis

The impact of aerobic exercise dose based on ACSM recommendations on patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

The impact of combined aerobic and resistance exercise on the prognosis of early Parkinson's disease patients

Aerobic Exercise Training Increases Brain Volume in Aging Humans

Distinct effects of long-term Tai Chi Chuan and aerobic exercise interventions on motor and neurocognitive performance in early-stage Parkinson's disease: a randomized controlled trial

High-intensity interval vs. continuous moderate-intensity aerobic exercise for improving neurotransmitter level and neurocognitive performance in individuals with Parkinson's disease